Genetic Technologies announced the introduction of geneType’s suite of genetic risk assessment tests to Canada and New Zealand. Dovetailing geneType’s recent expansion to the US market under its partnership with health and wellness technology leader Stayhealthy, the company is expanding its international presence four-fold in the second quarter of 2024. The geneType risk assessment test distribution in the new territories will be directed by Stayhealthy Canada and Stayhealthy New Zealand, respectively.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GENE:
- GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease
- GTG’s GeneType identifies 79.5% of people tested at risk of serious disease
- Join Genetic Technologies’ Exclusive Live Investor Webinar and Q&A Session on June 27
- Genetic Technologies expands operation capacity in North America
- GeneType , Stayhealthy announce distribution agreement for multi-risk test